Company Filing History:
Years Active: 2010-2020
Title: The Innovations of Shoichi Teshima
Introduction
Shoichi Teshima is a notable inventor based in Kitahiroshima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of multicomponent drugs. With a total of 2 patents, Teshima's work focuses on enhancing the accuracy and efficiency of drug formulation processes.
Latest Patents
Teshima's latest patents include a "Method of and apparatus for formulating multicomponent drug." This invention provides a method and apparatus capable of accurately formulating a multicomponent drug that meets productization criteria. The process involves obtaining a chromatogram from an extract or base of the drug, evaluating its suitability for productization, and processing it into a formulated drug with a specific dosage form. The evaluation is achieved through high-quality analysis using fingerprint area segmentation feature values derived from the chromatogram.
Another significant patent is the "Method and program for correcting peak position of spectrum waveform pattern." This invention addresses the need for accurate testing of product properties based on spectrum waveform patterns. The method involves setting reference peak positions and correcting peaks to ensure accurate evaluation of product quality.
Career Highlights
Throughout his career, Teshima has worked with reputable companies such as Angletry Associates and Tsumura & Co. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and drug formulation techniques.
Collaborations
Teshima has collaborated with notable colleagues, including Yoshikazu Mori and Keiichi Noda. These partnerships have likely enriched his research and development efforts in the pharmaceutical field.
Conclusion
Shoichi Teshima's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving drug formulation processes. His work continues to influence the field, paving the way for advancements in multicomponent drug development.